Dermata Therapeutics, Inc. (DRMA)
NCM · Biotechnology
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Peers in Biotechnology
All in industry →Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.
Recent press releases
Dermata Therapeutics, Inc. has not issued a press release in this window.
SEC filings
All filings →Dermata Therapeutics, Inc. has not filed an SEC document in this window.
Insider trades
All insider trades →Dermata Therapeutics, Inc. has no reported insider trades in the last 90 days.
Institutional holders
All holders →No 13F holdings have been reported for Dermata Therapeutics, Inc. in this window.
People at Dermata Therapeutics, Inc.
All people →Quarterly financials
Full financials →No quarterly financials have been ingested for Dermata Therapeutics, Inc..